Lexicon Pharmaceuticals, Inc. (LXRX) Presents At Citi's Biopharma Back To School Conference Transcript

Question-and-Answer SessionMichael ExtonCEO & Director Yes. No, absolutely. It's been a busy 2/3 of the year. And now that the kids are back at school, it's going to be a very busy back third, I'd say. So yes, look, it's been a very interesting year for us as we started the year pivoting back towards a pure R&D company to focus on the pipeline. And as a result of that, we've made great progress, I believe, across the main 3 assets that we have in the pipeline. And taking them somewhat chronologically, we -- ...